136 related articles for article (PubMed ID: 27790713)
21. Rac1 GTPase-deficient HeLa cells present reduced DNA repair, proliferation, and survival under UV or gamma irradiation.
Espinha G; Osaki JH; Magalhaes YT; Forti FL
Mol Cell Biochem; 2015 Jun; 404(1-2):281-97. PubMed ID: 25758356
[TBL] [Abstract][Full Text] [Related]
22. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
Zhao H; Jiao Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
[TBL] [Abstract][Full Text] [Related]
23. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
24. Expression of Rac1, HIF-1α, and VEGF in gastric carcinoma: correlation with angiogenesis and prognosis.
Zhan H; Liang H; Liu X; Deng J; Wang B; Hao X
Onkologie; 2013; 36(3):102-7. PubMed ID: 23485997
[TBL] [Abstract][Full Text] [Related]
25. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
26. [The effect of Rac1 siRNA on the biological behaviors of gastrointestinal cancer cells].
Huang J; Lan N; Liu M; Chen J; Zhou JT; Zhu YJ; Liu SR; Tang QL; Chen XZ; Bi F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):588-92. PubMed ID: 19764550
[TBL] [Abstract][Full Text] [Related]
27. Rac1 as a therapeutic anticancer target: Promises and limitations.
Bailly C; Beignet J; Loirand G; Sauzeau V
Biochem Pharmacol; 2022 Sep; 203():115180. PubMed ID: 35853497
[TBL] [Abstract][Full Text] [Related]
28. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
29. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
30. Role of hypoxia‑inducible factor‑2α in lung cancer (Review).
Wang WJ; Ouyang C; Yu B; Chen C; Xu XF; Ye XQ
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760175
[TBL] [Abstract][Full Text] [Related]
31. The VEGF pathway in lung cancer.
Alevizakos M; Kaltsas S; Syrigos KN
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1169-81. PubMed ID: 24085262
[TBL] [Abstract][Full Text] [Related]
32. RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer.
Tan S; Yi P; Wang H; Xia L; Han Y; Wang H; Zeng B; Tang L; Pan Q; Tian Y; Rao S; Oyang L; Liang J; Lin J; Su M; Shi Y; Liao Q; Zhou Y
Front Oncol; 2020; 10():649. PubMed ID: 32411607
[TBL] [Abstract][Full Text] [Related]
33. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
34. Rac1, A Potential Target for Tumor Therapy.
Liang J; Oyang L; Rao S; Han Y; Luo X; Yi P; Lin J; Xia L; Hu J; Tan S; Tang L; Pan Q; Tang Y; Zhou Y; Liao Q
Front Oncol; 2021; 11():674426. PubMed ID: 34079763
[TBL] [Abstract][Full Text] [Related]
35. MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1.
Zheng Z; Ding M; Ni J; Song D; Huang J; Wang J
Oncol Rep; 2015 Mar; 33(3):1291-9. PubMed ID: 25530132
[TBL] [Abstract][Full Text] [Related]
36. Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway.
Wang Y; Dong H; Zhu M; Ou Y; Zhang J; Luo H; Luo R; Wu J; Mao M; Liu X; Zhang J; Wei L
Eur J Pharmacol; 2010 Jun; 635(1-3):40-8. PubMed ID: 20307526
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple-negative breast cancer epithelial cells through the RhoA/Rac1 pathway.
Liang Y; Wang S; Zhang Y
Oncol Lett; 2018 Sep; 16(3):3481-3488. PubMed ID: 30127952
[TBL] [Abstract][Full Text] [Related]
38. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b.
Schnelzer A; Prechtel D; Knaus U; Dehne K; Gerhard M; Graeff H; Harbeck N; Schmitt M; Lengyel E
Oncogene; 2000 Jun; 19(26):3013-20. PubMed ID: 10871853
[TBL] [Abstract][Full Text] [Related]
39. Dominant negative Rac1 attenuates paclitaxel-induced apoptosis in human melanoma cells through upregulation of heat shock protein 27: a functional proteomic analysis.
Lee SC; Sim N; Clement MV; Yadav SK; Pervaiz S
Proteomics; 2007 Nov; 7(22):4112-22. PubMed ID: 17952876
[TBL] [Abstract][Full Text] [Related]
40. Effect of cyclic hydrodynamic pressure-induced proliferation of human bladder smooth muscle through Ras-related C3 botulinum toxin substrate 1, mitogen-activated protein kinase kinase 1/2 and extracellular regulated protein kinases 1/2.
Wu T; Chen L; Wei T; Wang Y; Xu F; Wang K
Int J Urol; 2012 Sep; 19(9):867-74. PubMed ID: 22574733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
